Effect of intravenous infusion of lidocaine on propofol dose in painless bronchoscopy: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022178

Enrollment

Unknown

Registered

2019-03-28

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless bronchoscope

Interventions

Experimental group:Intravenous infusion of lidocaine

Control group:0.9% NS

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who agree to undergo painless bronchoscopy; 2. ASA I~III; 3. Aged = 18 years old, male or female.

Exclusion criteria

Exclusion criteria: 1. maternal; 2. language communication barriers; 3. critical illness (preoperative ASA classification = IV); severe renal impairment (preoperative dialysis treatment); severe liver damage (Child-Pugh C); preoperative combined with severe heart disease, LVEF <30; 4. allergic history of propofol hydrochloride injection; 5. preoperative application of potential effects of neuromodulation drugs (stability, etc.); 6. Those who are intolerant to opioids.

Design outcomes

Primary

Measure	Time frame
Propofol dosage;	—

Countries

China

Contacts

Public ContactHao Wei

Hebei Provincial Hospital of Traditional Chinese Medicine

hao_wei800@qq.com+86 13832122359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026